Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 20, Issue 10, Pages 1357-1375
Publisher
Informa Healthcare
Online
2011-09-13
DOI
10.1517/13543784.2011.614230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies
- (2011) David S. Hong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeted therapy of thyroid cancer
- (2010) Steven I. Sherman BIOCHEMICAL PHARMACOLOGY
- Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma
- (2010) S.M. Coelho et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem Cells
- (2010) M. Todaro et al. CANCER RESEARCH
- Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
- (2010) R.C. Smallridge et al. CLINICAL ONCOLOGY
- A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer
- (2010) M A Trujillo et al. GENE THERAPY
- The Feasibility Study of Docetaxel in Patients with Anaplastic Thyroid Cancer
- (2010) K. Kawada et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- High Efficacy of Concomitant Treatment of Undifferentiated (Anaplastic) Thyroid Cancer with Radiation and Docetaxel
- (2010) Marlene Troch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Profound Hair and Skin Hypopigmentation in an African American Woman Treated With the Multi-Targeted Tyrosine Kinase Inhibitor Pazopanib
- (2010) Kostandinos Sideras et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
- (2010) A. R. Tan et al. ONCOLOGIST
- Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy
- (2010) Robert L. Foote et al. THYROID
- DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
- (2009) Melissa J LaBonte et al. BMC Medical Genomics
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
- (2009) V Gregorc et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005
- (2009) Amy Y. Chen et al. CANCER
- Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005
- (2009) L. Enewold et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Eruptive Keratoacanthoma-Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors
- (2009) KATHLEEN J. SMITH et al. DERMATOLOGIC SURGERY
- Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis
- (2009) Cristina Rodríguez-Antona et al. ENDOCRINE-RELATED CANCER
- Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
- (2009) Hendrieke Hoftijzer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
- (2009) Ning Jin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways
- (2009) Peng Hou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib
- (2009) Jean Philippe Arnault et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome
- (2009) Colin J. Mooney et al. THYROID
- Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect
- (2008) M Peled et al. CANCER GENE THERAPY
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
- (2008) Robert C Smallridge et al. ENDOCRINE-RELATED CANCER
- Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers
- (2008) Zhi Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- (2008) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
- (2008) Alex A. Adjei et al. JOURNAL OF CLINICAL ONCOLOGY
- Thyroid carcinoma: molecular pathways and therapeutic targets
- (2008) Yuri E Nikiforov MODERN PATHOLOGY
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer
- (2007) Libero Santarpia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now